Disc Medicine, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for IRON, updated each market day.
IRON AI Sentiment
AI predicts Disc Medicine, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Disc Medicine, Inc. Common Stock
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Sector
Exchange
Market Cap
$2,568,172,374
Cap Tier
Employees
155
Headquarters
WATERTOWN, MA
Listed Since
Feb. 8, 2021
Website
IRON Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
IRON Volatility
Disc Medicine, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
